2026· American journal of translational research· Vol 18 8, pp.
7189-7200
· 0 citations
Medicine
TL;DR
The validated nomogram established based on six routinely accessible clinical indicators can effectively and reliably predict the risk of in-hospital DVT in elderly patients with MCCs.
Abstract
Objective
To explore the independent influencing factors of deep venous thrombosis (DVT) in elderly patients with multiple chronic conditions (MCCs) and construct a predictive nomogram for this population.
Methods
A total of 689 elderly patients with MCCs who were hospitalized from January 2023 to March 2025 were retrospectively enrolled in this study. Patients were categorized into a DVT group (73 cases) and a non-DVT group (616 cases). The overall cohort was randomly split into a training set (482 cases) and an internal validation set (207 cases) at a 7:3 ratio. An additional 360 patients admitted from April 2025 to April 2026 were enrolled as an external validation cohort. Receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) were used to evaluate the performance of the predictive model.
Results
Age, MCCs number, polypharmacy, Padua score, limb muscle strength and DPR were identified as independent predicting factors for in-hospital DVT. The nomogram achieved an area under the curve (AUC) of 0.848. The AUC was 0.846 for the training set and 0.831 for the internal validation set, with good calibration. The external validation AUC was 0.807 with satisfactory calibration efficiency, and the DeLong test verified no significant difference in AUC values (P > 0.05). Furthermore, the model presented favorable clinical net benefits.
Conclusion
The validated nomogram established based on six routinely accessible clinical indicators can effectively and reliably predict the risk of in-hospital DVT in elderly patients with MCCs.
A nomogram based on five easily accessible variables demonstrated strong predictive performance for NASAI, offering a practical tool for early risk assessment in thrombolyzed AIS patients.
Xuan-Yue Yu, Ziqi Han, Dong Chen et al.· Journal of Cerebral Blood Fl...· 0 citations
The nomogram constructed in this study can serve as a preliminary risk stratification tool for HSP and holds promise for guiding early intervention in high-risk populations, but prospective multicenter studies are warranted to validate its generalizability and clinical utility.
Qian-Yang Xie, Yi-Fei Chen, Weijun Lun et al.· BMC Medical Informatics and...· 0 citations
This study aimed to identify factors associated with deep vein thrombosis (DVT) and to develop predictive models to facilitate individualized risk assessment in this population.
We retrospectively analyzed 240 patients with stroke admitted to a rehabilitation department, including 63 patients with DVT and 17...
Ya-Ping Wang, Wei-Lan Jiang, Yu-Meng Xing et al.· Frontiers in Neurology· 0 citations
Patients with sepsis are at high risk for venous thromboembolism (VTE). However, existing assessment tools designed for general medical or surgical populations may inadequately capture the specific risk profile of septic patients. This study aimed to identify independent predictors of VTE in sepsis and develop a se...
Yung-Hee Han, Ya-Ge Shi, Liu Liu et al.· Frontiers in Medicine· 0 citations
This study aimed to analyze risk factors for in-stent restenosis (ISR) following percutaneous coronary intervention (PCI) in patients with coronary heart disease and develop and validate a nomogram prediction model. Clinical data were retrospectively collected from 1135 patients with coronary heart disease who underwen...
Objective To investigate factors associated with gallstone occurrence in patients with type 2 diabetes and to establish a nomogram for predicting gallstone presence in this population, aiming to support early risk stratification and prevention-oriented management. Methods This retrospective study enrolled consecutive p...
Yang Zhao, Rui Su, Jun Li et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.